购物车
- 全部删除
- 您的购物车当前为空
T863 (DGAT-3) 是口服有效的二酰基甘油酰基转移酶1 选择性抑制剂。T863结合DGAT1的酰基辅酶A 结合位点,抑制三酰甘油在细胞内的合成。
为众多的药物研发团队赋能,
让新药发现更简单!
T863 (DGAT-3) 是口服有效的二酰基甘油酰基转移酶1 选择性抑制剂。T863结合DGAT1的酰基辅酶A 结合位点,抑制三酰甘油在细胞内的合成。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 322 | 现货 | |
2 mg | ¥ 455 | 现货 | |
5 mg | ¥ 713 | 现货 | |
10 mg | ¥ 1,230 | 现货 | |
25 mg | ¥ 2,430 | 现货 | |
50 mg | ¥ 3,590 | 现货 | |
100 mg | ¥ 5,120 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 785 | 现货 |
产品描述 | T-863(DGAT-1 inhibitor) is an orally active, selective and potent DGAT1 (Acyl-CoA:diacylglycerol acyltransferase 1) inhibitor that interacts with the acyl-CoA binding site of DGAT1, and inhibits triacylglycerol synthesis in cells. IC50 value: Target: DGAT1 T863 (DGAT-3) causes weight loss, reduction in serum and liver triglycerides, and improved insulin sensitivity in obese mice. |
别名 | DGAT-3, DGAT-1 inhibitor |
分子量 | 394.47 |
分子式 | C22H26N4O3 |
CAS No. | 701232-20-4 |
Smiles | CC1(C)Oc2ncnc(N)c2N=C1c1ccc(cc1)[C@H]1CC[C@H](CC(O)=O)CC1 |
密度 | 1.36 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 45 mg/mL (114.08 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容